Get the details in our Protein Powders Review + see our Top Picks among protein powders
4 weeks Minimum interval between dose increases 2mg to 12mg Phase 2 dose range (Jastreboff 2023) ~12 weeks Time to reach 12mg on standard protocol 24.2% Weight loss at 12mg, 48 weeks (Phase 2) Investigational Drug Warning Retatrutide (LY3437943) is not FDA-approved as of April 2026
Licensed providers conduct thorough evaluations via video or messaging, prescribe appropriate medications, and provide ongoing supervisionall without requiring in-person visits
Be careful when sourcing your own peptides online
Het batch-ID staat op de vial
It's important to note that skin health reflects numerous factors including nutritional status, hormonal balance, sleep quality, stress levels, and environmental exposures